AstraZeneca Stays Hopeful About Ultomiris Despite Initial Conversion Difficulties

Sales of Soliris Successor Stumble

Finger pressing light switch button.
AstraZeneca Wants Patients To Switch From Soliris To Ultomiris • Source: Alamy

More from Business

More from Scrip